MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1530/eje-10-0679

Медицинская библиотека · European journal of endocrinology · 2010

Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care.

Ramos Helton Estrela, Morandini Melina, Carré Aurore, Tron Elodie, Floch Corinne, Mandelbrot Laurent, Neri Nathalie, De Sarcus Benoit, Simon Albane, Bonnefont Jean Paul, Amiel Jeanne, Desguerre Isabelle, Valayannopoulos Vassili, Castanet Mireille, Polak Michel

Клинический случайСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CONTEXT: Monocarboxylate transporter 8 (MCT8 or SLC16A2) mutations cause X-linked Allan-Herndon-Dudley syndrome. Heterozygous females are usually asymptomatic, but pregnancy may modify thyroid function and MCT8 is expressed in the placenta, suggesting that maternal and fetal abnormalities might develop even in the absence of MCT8 fetal mutation. Genetic counseling is so far based on X-linked transmission, and prenatal diagnosis is rarely performed.

OBJECTIVE

To describe thyroid function and the prenatal diagnosis in pregnant mothers harboring heterozygous MCT8 mutations and management of the persistent maternal hypothyroxinemia. Patients Two women heterozygous for MCT8 mutations (c.1690G>A and c.1393-1G>C) were monitored throughout pregnancy.

METHODS

Prenatal diagnosis included sex determination, direct MCT8 sequencing, and familial linkage analysis. Ultrasonography and hormonal assays for maternal thyroid function evaluation were performed serially during pregnancy. Neonatal thyroid hormonal status was assessed.

RESULTS

None of the three fetuses (two males and one female) carried MCT8 mutations. One of the two heterozygous mothers revealed gestational hypothyroxinemia, prompting early levothyroxine (l-T₄) therapy until delivery. The second heterozygous mother showed normal thyroid function but was preventively traited by l-T₄ and all of the three neonates had normal thyroid hormone levels and thyroid gland at birth, suggesting advantages of prenatal care and/or compensatory mechanisms.

CONCLUSION

Heterozygous MCT8 women should be monitored for requirement of l-T₄ therapy to prevent fetal and neonatal hypothyroidism and to avoid risk of potential cognitive delay due to gestational hypothyroxinemia. Moreover, when the disease-causing mutation is known and/or the first child is affected, prenatal diagnosis for male fetuses should be assessed early for MCT8 mutations by direct sequencing.

Для цитирования: Ramos Helton Estrela, Morandini Melina, Carré Aurore, Tron Elodie, Floch Corinne, Mandelbrot Laurent, Neri Nathalie, De Sarcus Benoit, Simon Albane, Bonnefont Jean Paul, Amiel Jeanne, Desguerre Isabelle, Valayannopoulos Vassili, Castanet Mireille, Polak Michel. Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care.. European journal of endocrinology. 2010. DOI: 10.1530/eje-10-0679.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.